Intellogic, which develops the Botkin.AI project, raised 160 million rubles (equivalent to $2.1 million) as part of Round B to further develop their AI platform for medical research analysis.
Unicorn Capital Partners company became the lead investor. This company manages the PharmMed Innovations venture fund, which focuses on investments in the development of innovative drugs, medical devices and software for use in medicine. The co-investor of the round was the investment holding Tashir Medika, which specialises in financing and strategic development of assets in the healthcare sector.
Investments will be aimed at further development and scaling of the platform, expanding sales in Russia and entering international markets. Earlier, the Botkin.AI platform received the only registration certificate in Russia as a medical device with artificial intelligence technology with risk class of 2b.
Sergey Sorokin - CEO of Intellogic